Inventor · disambiguated record
Badrudin Rangoonwala
Also filed as: RANGOONWALA BADRUDIN
1 granted patent·9 pending applications·12 citations·filing 2003–2012
40Inventor score
Technology areasA61P
Top patents by PatentIndex Score
10 records- 0183US7368469B2Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted May 6, 2008·12 cites·94 claims
- 0261US2009258919A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failureAVENTIS PHARMA GMBH·Filed 2009·Application pending·0 cites
- 0359US2010267798A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTS PHARMA DEUTSCHLAND GMBH·Filed 2009·Application pending·0 cites
- 0458US2008125472A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 0557US2008287403A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2008·Application pending·0 cites
- 0653US2006194868A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 0753US2013317047A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTIS PHARMA GMBH·Filed 2012·Application pending·0 cites
- 0852US2005101658A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 0949US2011263619A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTIS PHARMA GMBH·Filed 2010·Application pending·0 cites
- 1049US2004087645A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →